J&J Appeal Of $2bn Talcum Powder Judgment Denied By US Supreme Court
Executive Summary
The Supreme Court said on 1 June that it would not review a $2bn verdict in Missouri for 22 women who alleged links between ovarian cancer and asbestos-tainted talc in Johnson’s Baby Powder. J&J believes the US' top court passed on an "extraordinary opportunity" that "leaves unresolved significant legal questions that state and federal courts will continue to face."
You may also be interested in...
J&J Cosmetic Talc Lawsuits Halted, $2Bn Trust Created, As Subsidiary Takes Liabilities Into Bankruptcy
Johnson & Johnson’s newly created subsidiary LTL Management LLC will take all cosmetic talc injury claims against the Johnson’s Baby Powder manufacturer into bankruptcy proceedings. J&J says the move is designed to ensure “equitable” resolution for all parties, while plaintiff’s attorneys have a decidedly different view on the matter.
Second-Quarter Consumer Health Results Bring J&J Relief From Year-Ago Sales Plummet
In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.
J&J’s Rumored Plan To End Talc Litigation Through Bankruptcy ‘Contemptible’ – Plaintiffs’ Attorneys
Plaintiffs’ attorneys blast J&J for reportedly considering weaseling out of its fiscal responsibilities by reorganizing its business away from talc liabilities, which could draw out tort proceedings and significantly reduce plaintiff awards, they suggest.